Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
169.2 USD | +0.70% | +0.68% | +9.18% |
12/07 | AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis | MT |
12/07 | AbbVie Seeks U.S., Europe OK of Rinvoq in Giant Cell Arteritis | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.18% | 30TCr | |
+61.53% | 86TCr | |
+38.95% | 63TCr | |
-3.66% | 36TCr | |
+15.06% | 32TCr | |
+5.89% | 23TCr | |
+16.53% | 23TCr | |
+15.67% | 18TCr | |
+2.47% | 16TCr | |
+2.41% | 13TCr |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Transcript : AbbVie Inc., Q4 2015 Earnings Call, Jan 29, 2016